-
The Million Women Study reported a small increase in the incidence of ovarian cancer and ovarian cancer mortality in current users of postmenopausal hormone therapy.
-
Human Papilloma Virus (HPV) is recognized worldwide as the principal culprit in the development of cervix cancer and its precursor dysplastic lesions. Also increasingly recognized is its role in other anogenital disease such as vulvar, vaginal and perianal warts, dysplasia and cancer.
-
In the May issue of the American Journal of Obstetrics and Gynecology, there was a report of a small randomized trial that might generate some cautious optimism regarding the treatment of PTL.
-
The Annual Meeting of the Society of Gynecologic Oncologists (SGO) represents the one completely focused platform to exchange preclinical and clinical information in the subspeciality of gynecologic oncology. This year more that 1300 health care providers, researchers and industry representatives participated in a conference offering much more than distribution of the latest scientific and clinical advances.
-
Worldwide, coffee is a popular beverage used daily with increasing frequency. Caffeine, a dominant ingredient, has been implicated in many conditions including hormonally active cancer (due to its impact on sex hormone binding globulin [SHBG] homeostasis).
-
There is no doubt now that the cervical length (CL) measurement, obtained with transvaginal ultrasound between 20 and 24 weeks, can give the clinician a very reasonable idea about which patients have the greatest and smallest chances of delivering preterm.
-
-
Gonococcal Infections, CDC's Updated Treatment; Head Lice Malathion First-Line Treatment; Statins, May Cut the Risk of Cataracts; FDA Actions
-
Has there been any progress in extracting information about the fetal chromosomes status from maternal blood samples?
-
E3N is a French prospective cohort study initiated in 1990. The participants are members of an insurance plan that covers mostly teachers.
